Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Editorial response: hyperlactatemia and hepatic steatosis as features of mitochondrial toxicity of nucleoside analogue reverse transcriptase inhibitors.

× No keyword cloud information.

12 in total

1. Reversible nucleoside analogue-associated lactic acidosis despite a prolonged course.

Authors: P Delobel; S Khatibi; M Alvarez; M Obadia; E Bonnet; P Massip; B Marchou
Journal: Intensive Care Med Date: 2003-04-09 Impact factor: 17.440

Review 2. [Adverse effects of antiretroviral therapy. Aspects of pathogenesis].

Authors: U Seybold; R Draenert; F D Goebel
Journal: Internist (Berl) Date: 2003-06 Impact factor: 0.743

3. Canadian consensus guidelines for the management of pregnancy, labour and delivery and for postpartum care in HIV-positive pregnant women and their offspring (summary of 2002 guidelines).

Authors: David R Burdge; Deborah M Money; John C Forbes; Sharon L Walmsley; Fiona M Smaill; Marc Boucher; Lindy M Samson; Marc Steben
Journal: CMAJ Date: 2003-06-24 Impact factor: 8.262

Review 4. Novel Approaches to Targeting Visceral and Hepatic Adiposities in HIV-Associated Lipodystrophy.

Authors: Phyllis C Tien
Journal: Curr Atheroscler Rep Date: 2015-12 Impact factor: 5.113

5. Mitochondrial oxidative phosphorylation protein levels in peripheral blood mononuclear cells correlate with levels in subcutaneous adipose tissue within samples differing by HIV and lipoatrophy status.

Authors: Cecilia M Shikuma; Mariana Gerschenson; Dominic Chow; Daniel E Libutti; John H Willis; James Murray; Roderick A Capaldi; Michael Marusich
Journal: AIDS Res Hum Retroviruses Date: 2008-10 Impact factor: 2.205

6. HIV-HCV Coinfection.

Authors: Amrita Sethi; Richard K Sterling
Journal: Gastroenterol Hepatol (N Y) Date: 2006-05

7. Treatment-limiting toxicities associated withnucleoside analogue reverse transcriptase inhibitor therapy: A prospective, observational study.

Authors: Rosario Palacios; Jesús Santos; Xavier Camino; Piedad Arazo; Rafael Torres Perea; Santiago Echevarrfa; Esteban Ribera; Rainel Sánchez de la Rosa; Santiago Moreno Guillen
Journal: Curr Ther Res Clin Exp Date: 2005-03

8. Adenosine 3',5'-cyclic monophosphate (cAMP)-dependent phosphoregulation of mitochondrial complex I is inhibited by nucleoside reverse transcriptase inhibitors.

Authors: Kaleb C Lund; Kendall B Wallace
Journal: Toxicol Appl Pharmacol Date: 2007-08-25 Impact factor: 4.219

Review 9. HIV viral suppression in the era of antiretroviral therapy.

Authors: H K Thaker; M H Snow
Journal: Postgrad Med J Date: 2003-01 Impact factor: 2.401

10. Mitochondrial DNA impairment in nucleoside reverse transcriptase inhibitor-associated cardiomyopathy.

Authors: James J Kohler; Seyed H Hosseini; William Lewis
Journal: Chem Res Toxicol Date: 2008-04-05 Impact factor: 3.739